Navigation Links
Tech Award Recognizes Vocantas for Commercialization Partnership, Development of World-leading Chronic Disease Management Solution
Date:4/17/2009

OTTAWA, April 17 /PRNewswire/ - Vocantas Inc., a developer of automated outreach solutions, was honoured to receive the Technology Commercialization Partnership award at the 14th annual OCRI Awards. The award was presented to Vocantas for the collective research and development that resulted in the successful implementation of its automated solution for chronic disease management, CallAssure.

Each year, OCRI (Ottawa Centre for Research and Innovation) presents the Technology Commercialization Partnership award to a company for its collaborative effort with a researcher (or a team of researchers) that has led to successful commercialization of a cutting-edge technology.

This year's win by Vocantas was based on recent work with numerous healthcare professionals and The Ottawa Hospital Thrombosis Program. The joint effort between Vocantas and its research partners has brought forth an innovative technology to improve communication between patients and caregivers, and to more efficiently manage chronic disease.

"I would like to thank all of the researchers and healthcare professionals at The Ottawa Hospital who have helped us with the development and commercialization of CallAssure," said Gary T. Hannah, president and CEO of Vocantas, upon accepting the award. "We look forward to a lasting partnership."

CallAssure is Vocantas' automated patient monitoring system that integrates dose technology with information regarding upcoming tests and notifications of any changes to the patient's care plan. Vocantas is now promoting its CallAssure product with confidence to hospitals and clinics across North America to help them better manage patients with chronic conditions.

The OCRI awards celebrate excellence in the areas of research, technology, entrepreneurship, leadership, partnership and student accomplishment. Over 60 nominations for the nine categories were received from Ottawa's business and education community last December and were reviewed by the Society of Collaborative Opportunities and Advancement of Professionals (SCOAP).

CallAssure is a registered trademark of Vocantas Inc. The names of other companies or products mentioned herein may be the trademarks of their respective owners.

About Vocantas

Vocantas is a developer of interactive voice response systems (IVRS) that use advanced computer telephony and speech technology to provide its customers with cost-effective customer outreach solutions. The company's easy-to-use, turn-key solutions offer customizable core features and optional enhancements that integrate seamlessly with existing systems. Its products have particular application in the healthcare, education, utilities and customer service environments where they have been proven to increase efficiencies while minimizing operational costs. For more information, please visit www.vocantas.com.


'/>"/>
SOURCE VOCANTAS
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Precyse Solutions Names 2008 Marquee Client Award Winners
2. Wellesse Receives Corporate Sponsor of the Year Award From the Arthritis Foundations Pacific Northwest Chapter
3. Zultys Inc. Receives 2009 NGN Leadership Award from NGN Magazine
4. Missouri Hospice & Palliative Care Association Recognizes Volunteers in Hospice With Heart of Hospice Awards Luncheon
5. One Family to Honor Sue Beaton with Founders Award
6. BIDMC scientists receive creativity awards from Prostate Cancer Foundation
7. Milton resident receives the Helen B. Spaulding Community Conscience Award
8. First Bringing Hope To Life Award to Howard Pete Love
9. Three Medical Centers Awarded Funds to Study Generation of Cardiac Muscle Cells
10. Smith & Wesson Security Services Wins Top Honors at SAMMY awards
11. DaVita Dietitian Receives 2009 National Kidney Foundation Award for Outstanding Contributions to Renal Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2017)... ... ... Juan Capistrano summer camp team at the Boys and Girls Club of South Coast ... physical activities for all campers. To read the report, click here or see ... specialty camps that focus on what the report terms as “sitting subjects” like coding or ...
(Date:4/21/2017)... ... April 21, 2017 , ... Chicago plastic surgeon, Dr. Anil ... An osteoma is a benign bony lump located on the forehead usually attributed to ... difficulties with sight and pain. Dr. Shah has discovered an approach that is minimally ...
(Date:4/21/2017)... ... ... The adage “Show, don’t tell” applies perfectly to Green Builder Media’s Earth ... House demonstration project series. Manifesting the concept of right-sized living, the Flex House is ... affordably and abundantly without unduly taxing the resources of our beautiful planet. ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... campaign, AWARE: A Week of Addiction and Recovery Education, from April 24 to ... and preventing substance use disorders. , The mission of AWARE is to ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... candidates to serve on its Accreditation and Standards Committees to support the ... is improving image quality and reducing patient radiation dose,” reports Eliot Siegel, ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
(Date:4/18/2017)... Ohio , April 18, 2017  Cardinal Health ... Non-GAAP 1 fiscal 2017 earnings per share (EPS) ... and 2019.  This is in conjunction with this morning,s ... Deep Vein Thrombosis and Nutritional Insufficiency businesses. ... from continuing operations will be at the bottom of ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, 2017 ... ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, and Cameron ... announced the signing of a three-year exclusive sales ... deploy a dedicated sales team to introduce Imprimis, ... primarily focused in 13 states in the U.S. ...
Breaking Medicine Technology: